Cargando…
Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety
Drug optimization, which improves drug potency/specificity by structure‒activity relationship (SAR) and drug-like properties, is rigorously performed to select drug candidates for clinical trials. However, the current drug optimization may overlook the structure‒tissue exposure/selectivity-relations...
Autores principales: | Gao, Wei, Hu, Hongxiang, Dai, Lipeng, He, Miao, Yuan, Hebao, Zhang, Huixia, Liao, Jinhui, Wen, Bo, Li, Yan, Palmisano, Maria, Traore, Mohamed Dit Mady, Zhou, Simon, Sun, Duxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136610/ https://www.ncbi.nlm.nih.gov/pubmed/35646532 http://dx.doi.org/10.1016/j.apsb.2022.02.015 |
Ejemplares similares
-
Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans
por: Li, Ying Fei, et al.
Publicado: (2018) -
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
por: Li, Yan, et al.
Publicado: (2020) -
Application of Y-STR, DIP-STR and SNP-STR Markers in Interpretation of Forensic Genetic Profiling: A Narrative Review
por: Forouzesh, Mehdi, et al.
Publicado: (2022) -
Engineering exosomes as refined biological nanoplatforms for drug delivery
por: Luan, Xin, et al.
Publicado: (2017) -
The landscape of human STR variation
por: Willems, Thomas, et al.
Publicado: (2014)